{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:57:32Z","timestamp":1770335852894,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.lfs.2024.123343","type":"journal-article","created":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T22:29:41Z","timestamp":1735511381000},"page":"123343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Altering phosphorylation of dystrophin S3059 to attenuate cancer cachexia"],"prefix":"10.1016","volume":"362","author":[{"given":"Kristy","family":"Swiderski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Trieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabel","family":"Chee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timur","family":"Naim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Brock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale M.","family":"Baum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey S.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin P.","family":"Hardee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenlan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Kueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco J.","family":"Herold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate T.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Gregorevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9220-9810","authenticated-orcid":false,"given":"Gordon S.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lfs.2024.123343_bb0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.lfs.2024.123343_bb0010","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1517\/14728210903369351","article-title":"Update on emerging drugs for cancer cachexia","volume":"14","author":"Murphy","year":"2009","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"2","key":"10.1016\/j.lfs.2024.123343_bb0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol. Rev."},{"issue":"7117","key":"10.1016\/j.lfs.2024.123343_bb0020","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/bmj.315.7117.1219","article-title":"ABC of palliative care. Anorexia, cachexia, and nutrition","volume":"315","author":"Bruera","year":"1997","journal-title":"Bmj"},{"issue":"4","key":"10.1016\/j.lfs.2024.123343_bb0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group","volume":"69","author":"Dewys","year":"1980","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.lfs.2024.123343_bb0030","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.122.4.809","article-title":"A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin","volume":"122","author":"Ervasti","year":"1993","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.lfs.2024.123343_bb0035","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.lfs.2024.123343_bb0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0960-8966(93)90002-2","article-title":"Deficiency of dystrophin-associated proteins: a common mechanism leading to muscle cell necrosis in severe childhood muscular dystrophies","volume":"3","author":"Matsumura","year":"1993","journal-title":"Neuromuscular Disorders: NMD"},{"key":"10.1016\/j.lfs.2024.123343_bb0045","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.exger.2016.08.006","article-title":"Age-related alterations in the sarcolemmal environment are attenuated by lifelong caloric restriction and voluntary exercise","volume":"83","author":"Hord","year":"2016","journal-title":"Exp. Gerontol."},{"issue":"5","key":"10.1016\/j.lfs.2024.123343_bb0050","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1152\/japplphysiol.00708.2007","article-title":"Modulation of the dystrophin-associated protein complex in response to resistance training in young and older men","volume":"104","author":"Kosek","year":"2008","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"2","key":"10.1016\/j.lfs.2024.123343_bb0055","doi-asserted-by":"crossref","first-page":"C500","DOI":"10.1152\/ajpcell.00529.2001","article-title":"Dystrophin-glycoprotein complex and Ras and Rho GTPase signaling are altered in muscle atrophy","volume":"283","author":"Chockalingam","year":"2002","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"5","key":"10.1016\/j.lfs.2024.123343_bb0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccr.2005.10.004","article-title":"Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia","volume":"8","author":"Acharyya","year":"2005","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.lfs.2024.123343_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123810","article-title":"The paradoxical effect of PARP inhibitor BGP-15 on irinotecan-induced cachexia and skeletal muscle dysfunction","volume":"12","author":"Campelj","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lfs.2024.123343_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107623","article-title":"Tyrosine phosphorylation as a regulator of dystrophin and beta-dystroglycan interaction: a molecular insight","volume":"99","author":"Abdullah","year":"2020","journal-title":"J. Mol. Graph. Model."},{"issue":"3","key":"10.1016\/j.lfs.2024.123343_bb0075","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1471-4159.2006.03904.x","article-title":"Phosphorylation of dystrophin Dp71d by Ca2+\/calmodulin-dependent protein kinase II modulates the Dp71d nuclear localization in PC12 cells","volume":"98","author":"Calderilla-Barbosa","year":"2006","journal-title":"J. Neurochem."},{"issue":"19","key":"10.1016\/j.lfs.2024.123343_bb0080","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1093\/hmg\/ddaa217","article-title":"Dystroglycan regulates proper expression, submembranous localization and subsequent phosphorylation of Dp71 through physical interaction","volume":"29","author":"Fujimoto","year":"2020","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.lfs.2024.123343_bb0085","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0898-6568(01)00188-7","article-title":"The interaction of dystrophin with beta-dystroglycan is regulated by tyrosine phosphorylation","volume":"13","author":"Ilsley","year":"2001","journal-title":"Cell. Signal."},{"issue":"Pt 10","key":"10.1016\/j.lfs.2024.123343_bb0090","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1242\/jcs.113.10.1717","article-title":"Adhesion-dependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin","volume":"113","author":"James","year":"2000","journal-title":"J. Cell Sci."},{"issue":"19","key":"10.1016\/j.lfs.2024.123343_bb0095","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1021\/bi00185a018","article-title":"Calmodulin-activated phosphorylation of dystrophin","volume":"33","author":"Madhavan","year":"1994","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.lfs.2024.123343_bb0100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0167-4838(99)00193-4","article-title":"Phosphorylation of dystrophin and alpha-syntrophin by Ca(2+)-calmodulin dependent protein kinase II","volume":"1434","author":"Madhavan","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.lfs.2024.123343_bb0105","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1139\/o96-047","article-title":"Phosphorylation of the carboxyl-terminal region of dystrophin","volume":"74","author":"Michalak","year":"1996","journal-title":"Biochemistry and cell biology = Biochimie et biologie cellulaire"},{"issue":"20","key":"10.1016\/j.lfs.2024.123343_bb0110","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1093\/hmg\/dds293","article-title":"Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse","volume":"21","author":"Miller","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"29","key":"10.1016\/j.lfs.2024.123343_bb0115","doi-asserted-by":"crossref","first-page":"21901","DOI":"10.1016\/S0021-9258(20)80626-7","article-title":"Phosphorylation of dystrophin. The carboxyl-terminal region of dystrophin is a substrate for in vitro phosphorylation by p34cdc2 protein kinase","volume":"268","author":"Milner","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2024.123343_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102847","article-title":"Phosphorylation alters the mechanical stiffness of a model fragment of the dystrophin homologue utrophin","volume":"299","author":"Ramirez","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2024.123343_bb0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/bbrc.1995.1009","article-title":"Phosphorylation of dystrophin:effects on actin binding","volume":"206","author":"Senter","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2024.123343_bb0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01076464","article-title":"Phosphorylation of the carboxyl terminal region of dystrophin by mitogen-activated protein (MAP) kinase","volume":"152","author":"Shemanko","year":"1995","journal-title":"Mol. Cell. Biochem."},{"issue":"48","key":"10.1016\/j.lfs.2024.123343_bb0135","doi-asserted-by":"crossref","first-page":"14585","DOI":"10.1021\/bi011247r","article-title":"Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins","volume":"40","author":"Sotgia","year":"2001","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.lfs.2024.123343_bb0140","doi-asserted-by":"crossref","first-page":"C956","DOI":"10.1152\/ajpcell.00513.2020","article-title":"Phosphorylation of ERK and dystrophin S3059 protects against inflammation-associated C2C12 myotube atrophy","volume":"320","author":"Swiderski","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"25","key":"10.1016\/j.lfs.2024.123343_bb0145","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1093\/hmg\/ddu388","article-title":"Phosphorylation within the cysteine-rich region of dystrophin enhances its association with beta-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting","volume":"23","author":"Swiderski","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.lfs.2024.123343_bb0150","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1046\/j.1471-4159.1994.62051947.x","article-title":"Tyrosine and serine phosphorylation of dystrophin and the 58-kDa protein in the postsynaptic membrane of Torpedo electric organ","volume":"62","author":"Wagner","year":"1994","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.lfs.2024.123343_bb0155","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1021\/bi0519957","article-title":"Binding of laminin alpha1-chain LG4-5 domain to alpha-dystroglycan causes tyrosine phosphorylation of syntrophin to initiate Rac1 signaling","volume":"45","author":"Zhou","year":"2006","journal-title":"Biochemistry"},{"issue":"13","key":"10.1016\/j.lfs.2024.123343_bb0160","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.16145","article-title":"Dystrophin S3059 phosphorylation partially attenuates denervation atrophy in mouse tibialis anterior muscles","volume":"12","author":"Swiderski","year":"2024","journal-title":"Physiol. Rep."},{"issue":"4","key":"10.1016\/j.lfs.2024.123343_bb0165","first-page":"533","article-title":"Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia","volume":"5","author":"Murphy","year":"2012","journal-title":"Dis. Model. Mech."},{"issue":"5","key":"10.1016\/j.lfs.2024.123343_bb0170","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/ijc.28128","article-title":"Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia","volume":"133","author":"Murphy","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2024.123343_bb0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2353\/ajpath.2010.090760","article-title":"Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology","volume":"176","author":"Gehrig","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2024.123343_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101157","article-title":"Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity","volume":"45","author":"Hardee","year":"2021","journal-title":"Mol Metab."},{"issue":"11","key":"10.1016\/j.lfs.2024.123343_bb0185","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1096\/fj.10-159608","article-title":"Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function","volume":"24","author":"Murphy","year":"2010","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.lfs.2024.123343_bb0190","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050502","article-title":"The BALB\/c.mdx62 mouse exhibits a dystrophic muscle pathology and is a model of Duchenne muscular dystrophy","volume":"17","author":"Swiderski","year":"2024","journal-title":"Dis. Model. Mech."},{"issue":"4","key":"10.1016\/j.lfs.2024.123343_bb0195","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1158\/0008-5472.CAN-18-1207","article-title":"Mas receptor activation slows tumor growth and attenuates muscle wasting in cancer","volume":"79","author":"Murphy","year":"2019","journal-title":"Cancer Res."},{"issue":"7221","key":"10.1016\/j.lfs.2024.123343_bb0200","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nature07414","article-title":"Sarcolemma-localized nNOS is required to maintain activity after mild exercise","volume":"456","author":"Kobayashi","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.lfs.2024.123343_bb0205","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00421-005-0022-7","article-title":"Gene expression in human skeletal muscle: alternative normalization method and effect of repeated biopsies","volume":"95","author":"Lundby","year":"2005","journal-title":"Eur. J. Appl. Physiol."},{"issue":"8","key":"10.1016\/j.lfs.2024.123343_bb0210","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","article-title":"Dystrophin protects the sarcolemma from stresses developed during muscle contraction","volume":"90","author":"Petrof","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"605","key":"10.1016\/j.lfs.2024.123343_bb0215","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay9592","article-title":"Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia","volume":"13","author":"Sartori","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.lfs.2024.123343_bb0220","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2005.10.016","article-title":"A signaling role for dystrophin: inhibiting skeletal muscle atrophy pathways","volume":"8","author":"Glass","year":"2005","journal-title":"Cancer Cell"},{"issue":"Pt 8","key":"10.1016\/j.lfs.2024.123343_bb0225","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1242\/jcs.02857","article-title":"Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex","volume":"119","author":"Judge","year":"2006","journal-title":"J. Cell Sci."},{"issue":"41","key":"10.1016\/j.lfs.2024.123343_bb0230","doi-asserted-by":"crossref","first-page":"39287","DOI":"10.1074\/jbc.M305551200","article-title":"Skeletal muscle signaling pathway through the dystrophin glycoprotein complex and Rac1","volume":"278","author":"Oak","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2024.123343_bb0235","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jcp.21684","article-title":"Dystrophin glycoprotein complex-associated Gbetagamma subunits activate phosphatidylinositol-3-kinase\/Akt signaling in skeletal muscle in a laminin-dependent manner","volume":"219","author":"Xiong","year":"2009","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123343_bb0240","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41467-020-14895-9","article-title":"A signaling hub of insulin receptor, dystrophin glycoprotein complex and plakoglobin regulates muscle size","volume":"11","author":"Eid Mutlak","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2024.123343_bb0245","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"16","key":"10.1016\/j.lfs.2024.123343_bb0250","doi-asserted-by":"crossref","first-page":"13216","DOI":"10.1074\/jbc.M111.224063","article-title":"Myocilin interacts with syntrophins and is member of dystrophin-associated protein complex","volume":"287","author":"Joe","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.lfs.2024.123343_bb0255","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1158\/0008-5472.CAN-19-1558","article-title":"MEF2c-dependent downregulation of myocilin mediates cancer-induced muscle wasting and associates with cachexia in patients with cancer","volume":"80","author":"Judge","year":"2020","journal-title":"Cancer Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524009330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524009330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T19:01:26Z","timestamp":1740337286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524009330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":51,"alternative-id":["S0024320524009330"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123343","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altering phosphorylation of dystrophin S3059 to attenuate cancer cachexia","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"123343"}}